Recalls & Warnings June 07, 2012 Recall of Digestive Health Supplement Due to Salmonella Concern On June 4, 2012, Botanical Laboratories of Ferndale, WA announced the recall of 38 bottles of 33.8 oz Wellese "Digestive 3 in 1 Health " liquid dietary supplement and 275 bottles of 16 oz
Obesity-related complications were identified within the 12-month period before index date (baseline) (Online Resource, p
Total Antioxidant Capacity as a Tool to Assess Redox Status: Critical View and Experimental Data
Surgery is a one-time expense but requires lifelong lifestyle adjustments
"Optimizing Needle Gauge Selection for Subcutaneous Injections: A Comprehensive Review." Journal of Diabetes Technology & Therapeutics, 24(5), 287-301
Key Points Glucagon-like peptide 1 receptor (GLP-1R) agonists lower blood pressure in patients with type 2 diabetes mellitus GLP-1R agonists have a long-term, weight-reducing effect in the majority of patients with type 2 diabetes Ischemic preconditioning and postconditioning with GLP-1R agonists results in a reduction of 50% in the size of myocardial infarctions in animal models, and inhibit myocardial stunning and dysfunction in humans GLP-1R agonists reduce the levels of biomarkers that have been linked to atherosclerotic cardiovascular disease and, therefore, might inhibit atherosclerosis development GLP-1R agonists might improve endothelial dysfunction To date, clinical studies of GLP-1R agonists have shown improvement, rather than impairment, in cardiovascular parameters This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
